Anticancer Potential of Water Fraction of Cashew Leaf (Anacardium occidentale L.) on A-375 Melanoma Cell Line In Vitro
DOI:
https://doi.org/10.33096/ke7ac573Abstract
Melanoma is an aggressive form of skin cancer with a high potential for metastasis and resistance to conventional therapies, highlighting the need for safer and more effective treatment alternatives. Natural products, particularly plant-derived compounds, have gained attention as promising sources of anticancer agents. This study aimed to evaluate the anticancer potential of the aqueous fraction of cashew leaves (Anacardium occidentale L.) against melanoma in vitro. Anticancer activity was assessed through cytotoxicity and cell migration assays. Cytotoxic effects were determined using the MTT assay on A-375 melanoma cells, while selectivity was evaluated using normal HaCaT keratinocyte cells. Antimetastatic activity was examined using a scratch wound healing assay to determine the ability of the fraction to inhibit cancer cell migration. The results demonstrated that the aqueous fraction exhibited cytotoxic activity against melanoma cells, with an IC₅₀ value of 184.29 ± 3.16 µg/mL, and showed good selectivity toward normal cells (SI = 6.68). Furthermore, the fraction significantly inhibited melanoma cell migration after 24 hours of treatment, indicating potential antimetastatic activity. This effect may be attributed to the presence of flavonoid and phenolic compounds, which are known to induce apoptosis and reduce oxidative stress. In conclusion, the aqueous fraction of A. occidentale leaves shows promising potential as a natural anticancer agent and may serve as a candidate for adjunctive therapy in melanoma treatment.
KEYWORDS: Anticancer; MTT cytotoxicity; cashew leaves; cell migration.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Fitria Nurcahyani, Adryan Fristiohady, Wahyuni, Sahidin, Suryani, Irnawati, Jumriani, La Ode Muh. Julian Purnama

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
- The author must submit Copyright form After acceptance of the article.